BRIM Biotechnology, Inc. (TPE:6885)
Taiwan · Delayed Price · Currency is TWD 20.35
-0.10 (-0.49%)
Aug 19, 2026, 1:30 PM CST
BRIM Biotechnology Market Cap
BRIM Biotechnology has a market cap or net worth of 2.72 billion as of August 19, 2026. Its market cap has decreased by -33.36% in one year.
Market Cap
2.72B
Enterprise Value
1.82B
Revenue
10.60M
Ranking
n/a
PE Ratio
n/a
Stock Price
20.35
ChartMarket Cap Chart
Since June 23, 2022, BRIM Biotechnology's market cap has increased from 1.77B to 2.72B, an increase of 54.04%. That is a compound annual growth rate of 10.95%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 19, 2026 | 2.72B | -31.36% |
| Dec 31, 2025 | 3.96B | -2.58% |
| Dec 31, 2024 | 4.07B | 17.34% |
| Dec 29, 2023 | 3.47B | -2.55% |
| Dec 30, 2022 | 3.56B | 101.45% |
| Jun 23, 2022 | 1.77B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sagittarius Life Science | 3.30B |
| Shine-On BioMedical | 3.14B |
| Apex Biotechnology | 3.10B |
| Great Novel Therapeutics Biotech & Medicals | 3.07B |
| 3D Global Biotech | 2.89B |
| Intech Biopharm | 2.87B |
| Chunghwa Chemical Synthesis & Biotech | 2.69B |
| Energenesis Biomedical CO.,LTD. | 2.67B |